Dechra Pharmaceuticals (DPH) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Dechra Pharmaceuticals

NOTE: This is based on 141 open tips for Dechra Pharmaceuticals (DPH)


Dechra Pharmaceuticals (DPH)
Latest Quote Price

3,866.00p

Dechra Pharmaceuticals (DPH)
Price Change (%)

0.05%


Latest Bid : 3,864.00p Latest Ask : 3,868.00p
High Today : 3,866.00p Low Today : 3,864.00p
This Years High : 3,866.00p This Years Low : 2,544.00p
Volume : 11,383 MKT Cap : £4368.58M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Dechra Pharmaceuticals (DPH) Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Dechra Pharmaceuticals (DPH) Latest Tips

Type Tipster SectorScore Start date Performance
Outperform RBC Capital Premium Only 2022-07-05 05:50:00 05/07/2022 11.69%
Hold Jefferies Premium Only 2022-04-26 04:50:00 26/04/2022 -4.01%
Long Term Buy Alan Oscroft Premium Only 2022-04-06 12:25:00 06/04/2022 -8.05%
Buy Lucy Tobin Premium Only 2022-04-03 15:15:00 03/04/2022 -5.06%
Long Term Buy Andrew Woods Premium Only 2022-03-18 15:10:00 18/03/2022 -7.92%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Dechra Pharmaceuticals (DPH) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 3,864.00p Latest Ask : 3,868.00p
High Today : 3,866.00p Low Today : 3,864.00p
This Years High : 3,866.00p This Years Low : 2,544.00p
Volume : 11,383 MKT Cap : £4368.58M

Dechra Pharmaceuticals Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Dechra Pharmaceuticals Tips

Type Tipster SectorScore Start date Performance
Outperform RBC Capital Premium Only 2022-07-05 05:50:00 05/07/2022 11.69%
Hold Jefferies Premium Only 2022-04-26 04:50:00 26/04/2022 -4.01%
Long Term Buy Alan Oscroft Premium Only 2022-04-06 12:25:00 06/04/2022 -8.05%
Buy Lucy Tobin Premium Only 2022-04-03 15:15:00 03/04/2022 -5.06%
Long Term Buy Andrew Woods Premium Only 2022-03-18 15:10:00 18/03/2022 -7.92%